Journals / Medicine Science / 2014 / Cilt: 3 Sayı: 2

HBV, HCV and HIV Seroprevalence in Soldiers Tested for Carriership

Özcan Deveci1, Cem Uysal2*, RecepTekin1, Alicem Tekin3, Müzeyyen Ay4, Fatma

Pages
1234–1240
Publication Date
2014-06-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially individuals who are employed in sectors where the transmission risk is high should be periodically scanned and monitored for infection and diseases caused by these viruses.Key words: HBV, HCV, HIV, seroprevalence, risk groups, troops

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractIndividuals employed or recruited to work in tourism, cleaning and food sectors and the men performing their military service in the food and cleaning services in the military are requested to undergo scans for the hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency (HIV) viruses as part of the carrier testing.
📊
Key Findings & Data:The study was conducted in the Kiziltepe State Hospital through the retrospective evaluation of the records of the soldiers who presented to the infectious diseases clinic between March 2010 and December 2012 for carriership scans.
💡
Conclusion & Impact:Especially individuals who are employed in sectors where the transmission risk is high should be periodically scanned and monitored for infection and diseases caused by these viruses.Key words: HBV, HCV, HIV, seroprevalence, risk groups, troops
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:HBV · HCV · HIV

Abstract

AbstractIndividuals employed or recruited to work in tourism, cleaning and food sectors and the men performing their military service in the food and cleaning services in the military are requested to undergo scans for the hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency (HIV) viruses as part of the carrier testing. The aim of the present study is to evaluate the seroprevalence of HBV, HCV and HIV in the soldiers scanned in terms of carriership. The study was conducted in the Kiziltepe State Hospital through the retrospective evaluation of the records of the soldiers who presented to the infectious diseases clinic between March 2010 and December 2012 for carriership scans. The HBV, HCV, and HIV tests were carried out in the central laboratory of the Kiziltepe State Hospital through the micro particle enzyme immunoassay (MEIA) method using the Axsym Plus Immunoassay Auto Analyzer (Abbott Laboratories, Abbott Park, Illinois, USA). The records of 367 soldiers between the ages of 20-22 were included in the study. Among these, 5 (1.36%) were HBsAg and 2 (0.55%) were anti-HCV positive, while none of them were positive for HIV. In order to reduce the risk of HBV, HCV and HIV infections, which are mainly transmitted through blood and sexual intercourse, preventive measures should be taken, education should be given and awareness should be increased. Especially individuals who are employed in sectors where the transmission risk is high should be periodically scanned and monitored for infection and diseases caused by these viruses.Key words: HBV, HCV, HIV, seroprevalence, risk groups, troops

Özet

-

🔖

Cite This Article

DEVECİ, Ö., UYSAL, C., TEKİN, R., TEKİN, A., AY, M., BOZKURT, F., DAYAN, S. (2014). HBV, HCV and HIV Seroprevalence in Soldiers Tested for Carriership. Medicine Science, Cilt: 3 Sayı: 2, 1234–1240. https://ajindex.com/articles/1003280

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral Hepatitis B. Lancet. 2003;362(9401): 2089-94. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24):1733-45. Marco M. The Hepatitis Report: Epidemiology, modes of transmission and risk factors for Hepatitis C virus. http://www.thebody.com/content/art1696.html access date 09.07.2000 Eyigün CP, Avcı İY. Hepatit B ve D virüsleri. In: Başustaoğlu A, Kubar A, Yıldıran ŞT, Tanyüksel M, eds, Klinik Mikrobiyoloji. Ankara: Atlas Kitapçılık; 2009; 1641-59. Taşyaran MA. HBV Enfeksiyonu epidemiyolojisi. In: Kılıçturgay K, Badur S, eds, Viral Hepatit. İstanbul: Deniz Ofset; 2000; 121-8.
  2. Özsoy MF, Öncül O, Çavuşlu S, Erdemoğlu A, Emekdaş G, Pahsa A. Seroprevalences of hepatitis B and C among health care workers in Turkey. Journal of Viral Hepatitis. 2004;10(2):150-6. Akça G. Diş hekimliğinde kan yoluyla bulaşan viral enfeksiyonlar ve önemi. Hastane İnfeksiyonları Derg. 2008;12(1):5-10. WHO. World Health Organization Report: Hepatitis B. http://www.who.int/mediacentre/factsheets access date 18.06.2013 Kantarçeken B. Kronik Hepatit B-doğal seyir. In: Tabak F, Balık İ, eds, Viral Hepatit. İstanbul: Viral Hepatitle Savaşım Derneği Yayını; 2009; 3-22. Badur S. 2007 yılında AIDS: Nereden nereye geldik? ANKEM Derg. 2007;21(Ek 2):1-6.
  3. Kalaycı R, Balcı H, Akdemir Y, Altındiş M. Halk sağlığı laboratuvarına başvuran portörlerde HBsAg sıklığı. Viral Hepatit Derg. 2012;18(1):57-9. Tosun M. Türkiye’de viral Hepatit B epidemiyolojisi yayınlarının metaanalizi. In: Tabak F, Tosun S, eds, Viral Hepatit. İstanbul: İstanbul Medikal Yayıncılık; 2013; 25-81. Mıstık R. Hepatit C virüs enfeksiyonunun epidemiyolojisi. In: Tabak F, Tosun S, eds, Viral Hepatit. İstanbul: İstanbul Medikal Yayıncılık; 2013; 83-112.
  4. Akcam Z, Akcam M, Coşkun M, Sunbul M. Hastane personelinin viral hepatitler ve hepatit B aşısı ile ılgili bilgi düzeyinin değerlendirilmesi. Viral Hepatit Derg. 2003;8(1):32-5.
  5. Polat M, Oğut S, Orhan H, Sucaklı MB. Isparta ve Burdur’da çalışan hemşirelerin hepatit B virüs enfeksiyonu konusundaki bilgi, tutum ve davranışları. Viral Hepatit Derg. 2006;11(2):89-94.
  6. Mıstık R, Balık İ. Türkiye’ de viral hepatitlerin epidemiyolojik analizi. In: Tekeli E, Balık İ, Tekeli E, eds, Viral Hepatit. İstanbul: Deniz Ofset; 2003;10-55.
  7. Kocak N, Hepgul S, Ozbayburtlu S, Altunay H, Ozsoy MF, Kosan E, Aksu Y, Yilmaz G, Pahsa A. Trends in major transfusion-transmissible ınfections among blood donors over 17 years in Istanbul, Turkey. J Int Med Res. 20